Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL

Cell Death and Differentiation

Volumn 19, Issue 11, 2012, Pages 1802-1814

  Chi, H C ^a   Chen, S L ^b   Liao, C J ^a   Liao, C H ^a   Tsai, M M ^a,c   Lin, Y H ^a   Huang, Y H ^d   Yeh, C T ^d   Wu, S M ^a   Tseng, Y H ^a   Chen, C Y ^a   Tsai, C Y ^a   Chung, I H ^a   Chen, W J ^d   Lin, K H ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

apoptosis; metastasis; thyroid hormone receptor; TRAIL

Indexed keywords

BCR ABL PROTEIN; THYROID HORMONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; MICE, SCID; NEOPLASM METASTASIS; RECEPTORS, THYROID HORMONE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION, HETEROLOGOUS; TRIIODOTHYRONINE; UP-REGULATION;

EID: 84870974529     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.58     Document Type: Article

References (38)

1. Huang YH, Tsai MM, Lin KH. Thyroid hormone dependent regulation of target genes and theirphysiological significance. Chang Gung Med J 2008; 31: 325-334.
2. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A. Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 2003; 192:121-132.
3. Barlow C, Meister B, Lardelli M, Lendahl U, Vennstrom B. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. Embo J 1994; 13: 4241-4250.
4. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A et al. Thec-erb-Aproteinisa high-affinity receptor for thyroid hormone. Nature 1986; 324: 635-640.
5. Lin KH, Shieh HY, Chen SL, Hsu HC. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 1999; 26: 53-61.
6. Chan IH, Privalsky ML. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 2006; 25: 3576-3588.
7. Chan IH, Privalsky ML. Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene 2009; 28: 4162-4174.
8. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 2006; 66: 7270-7275.
9. Plateroti M, Kress E, Mori JI, Samarut J. Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Mol Cell Biol 2006; 26: 3204-3214.
10. Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011;30: 2057-2069.
11. Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY, et al. Cooperation between the thyroid hormone receptor TRα1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 2010; 138:1863-1874; e1.
12. Iishi H, Tatsuta M, Baba M, Okuda S, Taniguchi H. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane. Int J Cancer 1992; 50: 974-976.
13. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-682.
14. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-12690.
15. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008; 8: 782-798.
16. Trauzold A, Siegmund D, Schniewind B, Sipos B, Egberts J, Zorenkov D, et al. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 2006; 25: 7434-7439.
17. Ehrenschwender M, Siegmund D, Wicovsky A, Kracht M, Dittrich-Breiholz O, Spindler V, et al. Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation. Cell Death Differ 2010; 17:1435-1447.
18. Ishimura N, Isomoto H, Bronk SF, Gores GJ. Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2006; 290: G129-G136.
19. Hoogwater FJ, Nijkamp MW, Smakman N, Steller EJ, Emmink BL, Westendorp BF, et al. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancercells. Gastroenterology 2010; 138: 2357-2367.
20. Fingas CD, Blechacz BRA, Smoot RL, Guicciardi ME, Mott J, Bronk SF, et al. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology 2010; 52: 550-561.
21. Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S. Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. Clin Cancer Res 2003; 9: 3397-3405.
22. Ozawa F, Friess H, Kleeff J, Xu ZW, Zimmermann A, Sheikh MS, et al. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Lett 2001; 163: 71-81.
23. Zender L, Hutker S, Mundt B, Waltemathe M, Klein C, Trautwein C, et al. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. Hepatology 2005; 41: 280-288.
24. Muhlethaler-Mottet A, Bourloud KB, Auderset K, Joseph JM, Gross N. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Oncogene 2004; 23: 5415-5425.
25. Malhi H, Gores GJ. TRAIL resistance results incancerprogression: aTRAILtoperdition? Oncogene 2006; 25: 7333-7335.
26. Guigon CJ, Cheng SY. Novel oncogenic actions of TRbeta mutants in tumorigenesis. IUBMB Life 2009; 61: 528-536.
27. Martinez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM, et al. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 2009; 69: 501-509.
28. Hall LC, Salazar EP, Kane SR, Liu N. Effects of thyroid hormonesonhumanbreastcancer cell proliferation. J Steroid Biochem Mol Biol 2008; 109: 57-66.
29. Rae MT, Gubbay O, Kostogiannou A, Price D, Critchley HO, Hillier SG. Thyroid hormone signaling in human ovarian surface epithelial cells. J Clin Endocrinol Metab 2007; 92: 322-327.
30. Hetschko H, Voss V, Horn S, Seifert V, Prehn JH, Kogel D. Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. J Neurooncol 2008; 86: 265-272.
31. Secchiero P. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 2003; 107: 2250-2256.
32. Wei W, Wang D, Shi J, Xiang Y, Zhang Y, Liu S et al. Tumor necrosisfactor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway. Mol Immunol 2010; 47: 2475-2484.
33. Grimm M, Kim M, Rosenwald A, von Rahden B, Tsaur I, Meier E, et al. Tumour-mediated TRAIL-receptor expression indicates effective apoptotic depletion of infiltrating CD8 + immune cells in clinical colorectal cancer. Eur J Cancer 2010; 46: 2314-2323.
34. Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005; 128:1796-1804.
35. Zhou DH, Trauzold A, Roder C, Pan G, Zheng C, Kalthoff H. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell. Hepatobiliary Pancreat Dis Int 2008; 7: 201-209.
36. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17: 463-516.
37. Kim JH, Choi C, Benveniste EN, Kwon D. TRAIL induces MMP-9 expression via ERK activation in human astrocytoma cells. Biochem Biophys Res Commun 2008; 377: 195-199.
38. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, et al. Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Cancer Sci 2011; 102: 2255-2263.